Studies examining RHOBTB2 as a tumor suppressor show that decreased levels of RHOBTB2, through variants, epigenetic modifications, or silencing mechanisms, are associated with multiple cancers (28, 29, 31, 33, 36). Here, RHOBTB2 is linked to neoplasm.